Involvement of the oncogenic small nucleolar RNA SNORA24 in regulation of p53 stability in colorectal cancer

© 2022. The Author(s), under exclusive licence to Springer Nature B.V..

Colorectal cancer (CRC) is a common malignant cancer worldwide. Although the molecular mechanism of CRC carcinogenesis has been studied extensively, the details remain unclear. Small nucleolar RNAs (snoRNAs) have recently been reported to have essential functions in carcinogenesis, although their roles in CRC pathogenesis are largely unknown. In this study, we found that the H/ACA snoRNA SNORA24 was upregulated in various cancers, including CRC. SNORA24 expression was significantly associated with age and history of colon polyps in CRC patient cohorts, with high expression associated with a decreased 5-year overall survival. Our results indicated that the oncogenic function of SNORA24 is mediated by promoting G1/S phase transformation, cell proliferation, colony formation, and growth of xenograft tumors. Furthermore, SNORA24 knockdown induced massive apoptosis. RNA-sequencing and gene ontology (GO) enrichment analyses were performed to explore its downstream targets. Finally, we confirmed that SNORA24 regulates p53 protein stability in a proteasomal degradation pathway. Our study clarifies the oncogenic role of SNORA24 in CRC and advance the current model of the role of the p53 pathway in this process.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:39

Enthalten in:

Cell biology and toxicology - 39(2023), 4 vom: 10. Aug., Seite 1377-1394

Sprache:

Englisch

Beteiligte Personen:

Shen, Liping [VerfasserIn]
Lin, Chuxian [VerfasserIn]
Lu, Wenqing [VerfasserIn]
He, Junyan [VerfasserIn]
Wang, Qi [VerfasserIn]
Huang, Yujv [VerfasserIn]
Zheng, Xiaofei [VerfasserIn]
Wang, Zhidong [VerfasserIn]

Links:

Volltext

Themen:

Colorectal cancer (CRC)
H/ACA snoRNA
Journal Article
P53
RNA, Small Nucleolar
Research Support, Non-U.S. Gov't
SNORA24
Tumor Suppressor Protein p53

Anmerkungen:

Date Completed 16.08.2023

Date Revised 20.08.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s10565-022-09765-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM346041767